Center for Neurodegenerative Disease and Therapeutics, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, USA.
School of Graduate and Postdoctoral Studies, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, USA.
Alzheimers Dement. 2023 Aug;19(8):3701-3717. doi: 10.1002/alz.13065. Epub 2023 May 3.
This review discusses the driving principles that may underlie neurodegeneration in dementia, represented most dominantly by Alzheimer's disease (AD). While a myriad of different disease risk factors contribute to AD, these ultimately converge to a common disease outcome. Based on decades of research, a picture emerges where upstream risk factors combine in a feedforward pathophysiological cycle, culminating in a rise of cytosolic calcium concentration ([Ca ] ) that triggers neurodegeneration. In this framework, positive AD risk factors entail conditions, characteristics, or lifestyles that initiate or accelerate self-reinforcing cycles of pathophysiology, whereas negative risk factors or therapeutic interventions, particularly those mitigating elevated [Ca ] , oppose these effects and therefore have neuroprotective potential.
这篇综述讨论了可能导致痴呆症中神经退行性变的驱动原则,以阿尔茨海默病(AD)最为突出。虽然有无数不同的疾病风险因素导致 AD,但这些因素最终都汇聚到一个共同的疾病结果上。基于数十年的研究,出现了这样一幅画面:上游风险因素在一个前馈病理生理循环中结合在一起,最终导致细胞溶质钙浓度([Ca 2+ ])升高,引发神经退行性变。在这个框架中,AD 的阳性风险因素涉及引发或加速自我强化病理生理循环的条件、特征或生活方式,而阴性风险因素或治疗干预措施,特别是那些减轻升高的[Ca 2+ ]的措施,会对抗这些效应,因此具有神经保护潜力。
Alzheimers Dement. 2025-5
IEEE J Transl Eng Health Med. 2025-4-10
Psychiatriki. 2025-5-14
Inflammopharmacology. 2025-8-27
Front Aging Neurosci. 2025-4-29
Neurodegener Dis Manag. 2025
Signal Transduct Target Ther. 2025-3-21
J Clin Invest. 2023-1-17
Proc Natl Acad Sci U S A. 2022-12-6
Nat Rev Neurosci. 2023-1
Mol Psychiatry. 2023-1